Other News To Note
Wednesday, April 20, 2011
Omeros Corp., of Seattle, said research on mannan-binding lectin-associated serine protease-2 (MASP-2) published in the Proceedings of the National Academy of Sciences showed blocking MASP-2 function significantly reduced tissue damage caused by ischemia-reperfusion injury. Researchers showed that, in animal models of cardiac and gastrointestinal ischemia-reperfusion injury, inhibition of MASP-2 function blocked the excessive inflammatory responses, resulting in less tissue damage.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.